[Autologous serum and alternative blood products for the treatment of ocular surface disorders]
- PMID: 18607606
- DOI: 10.1007/s00347-008-1750-y
[Autologous serum and alternative blood products for the treatment of ocular surface disorders]
Abstract
Eye drops made from autologous serum have been increasingly used in the past decade to treat ocular surface disorders such as persistent epithelial defects and dry eye. Due to biologically active ingredients such as growth factors, vitamins, and nutrients, they can be used to lubricate the ocular surface and support epithelial wound healing. According to current legal requirements, they can be dispensed only for outpatient treatment if the producer has obtained a license from the appropriate local authorities. Therefore, the production and dispensing of autologous serum eye drops in Germany is currently limited to a very few institutions and their patients. We review the current evidence on the use of serum eye drops, recommend a standard protocol for their production, and describe a number of recently emerging alternative blood products for the treatment of ocular surface diseases along with their potential advantages and limitations.
Similar articles
-
[On the use of autologous serum eyedrops in Germany : results of a survey among members of the Cornea Section of the German Ophthalmological Society (DOG)].Ophthalmologe. 2008 Jul;105(7):644-9. doi: 10.1007/s00347-008-1776-1. Ophthalmologe. 2008. PMID: 18612645 German.
-
[Albumin eye drops for treatment of ocular surface diseases].Ophthalmologe. 2009 Oct;106(10):932-7. doi: 10.1007/s00347-009-2057-3. Ophthalmologe. 2009. PMID: 19813016 Review. German.
-
Blood derived eye drops for the treatment of cornea and ocular surface diseases.Transfus Apher Sci. 2017 Aug;56(4):595-604. doi: 10.1016/j.transci.2017.07.023. Epub 2017 Aug 8. Transfus Apher Sci. 2017. PMID: 28844373 Review.
-
Autologous serum for ocular surface diseases.Arq Bras Oftalmol. 2008 Nov-Dec;71(6 Suppl):47-54. Arq Bras Oftalmol. 2008. PMID: 19274411 Review.
-
[Autologous serum-eye-drops for ocular surface disorders. A literature review and recommendations for their application].Ophthalmologe. 2002 Dec;99(12):949-59. doi: 10.1007/s00347-002-0661-6. Ophthalmologe. 2002. PMID: 12478384 German.
Cited by
-
Hyaluronic Acid as an Alternative to Autologous Human Serum Eye Drops: Initial Clinical Results with High-Molecular-Weight Hyaluronic Acid Eye Drops.Case Rep Ophthalmol. 2019 Aug 6;10(2):244-255. doi: 10.1159/000501712. eCollection 2019 May-Aug. Case Rep Ophthalmol. 2019. PMID: 31692577 Free PMC article.
-
[Diagnosis and treatment of the watering eye].HNO. 2017 Jan;65(1):69-84. doi: 10.1007/s00106-016-0286-8. HNO. 2017. PMID: 27904918 Review. German.
-
Allogeneic serum eye drops for the treatment of dry eye patients with chronic graft-versus-host disease.J Ocul Pharmacol Ther. 2012 Oct;28(5):479-83. doi: 10.1089/jop.2012.0002. Epub 2012 Jun 25. J Ocul Pharmacol Ther. 2012. PMID: 22731244 Free PMC article. Clinical Trial.
-
[On the use of autologous serum eyedrops in Germany : results of a survey among members of the Cornea Section of the German Ophthalmological Society (DOG)].Ophthalmologe. 2008 Jul;105(7):644-9. doi: 10.1007/s00347-008-1776-1. Ophthalmologe. 2008. PMID: 18612645 German.
-
Autologous serum eye drops for dry eye.Cochrane Database Syst Rev. 2013 Aug 27;8(8):CD009327. doi: 10.1002/14651858.CD009327.pub2. Cochrane Database Syst Rev. 2013. Update in: Cochrane Database Syst Rev. 2017 Feb 28;2:CD009327. doi: 10.1002/14651858.CD009327.pub3. PMID: 23982997 Free PMC article. Updated.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous